Skip to main content
SpringerLink
Log in

Natriuretic peptides: biomarkers for atrial fibrillation management

  • Review
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hong KL, Glover BM (2018) The impact of lifestyle intervention on atrial fibrillation. Curr Opin Cardiol 33(1):14–19

    Article  Google Scholar 

  2. Berge T, Brynildsen J, Larssen HKN, Onarheim S, Jenssen GR, Ihle-Hansen H, Christophersen IE, Myrstad M, Rosjo H, Smith P, Tveit A (2017) Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the akershus cardiac examination 1950 study. Europace 00:1–7. https://doi.org/10.1093/europace/eux293

    Article  Google Scholar 

  3. Guerra F, Brambatti M, Nieuwlaat R, Marcucci M, Dudink E, Crijns H, Matassini MV, Capucci A (2017) Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Europace 19(12):1922–1929. https://doi.org/10.1093/europace/eux205

    Article  PubMed  Google Scholar 

  4. Zimetbaum P (2017) Atrial fibrillation. Ann Intern Med 166(5):33–48. https://doi.org/10.7326/aitc201703070

    Article  Google Scholar 

  5. Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Marquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Group ESCSD (2018) European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Europace 20(9):1399–1421. https://doi.org/10.1093/europace/euy046

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wintgens L, Romanov A, Phillips K, Ballesteros G, Swaans M, Folkeringa R, Garcia-Bolao I, Pokushalov E, Boersma L (2018) Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. Europace 20(11):1783–1789. https://doi.org/10.1093/europace/euy025

    Article  PubMed  Google Scholar 

  7. Sepehri Shamloo A, Dagres N, Mussigbrodt A, Stauber A, Kircher S, Richter S, Dinov B, Bertagnolli L, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A (2019) Atrial fibrillation and cognitive impairment: new insights and future directions. Heart Lung Circ. https://doi.org/10.1016/j.hlc.2019.05.185

    Article  PubMed  Google Scholar 

  8. Wakula P, Neumann B, Kienemund J, Thon-Gutschi E, Stojakovic T, Manninger M, Scherr D, Scharnagl H, Kapl M, Pieske B, Heinzel FR (2017) CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation. Europace 19(4):544–551. https://doi.org/10.1093/europace/euw101

    Article  PubMed  Google Scholar 

  9. Reihani H, Sepehri Shamloo A, Keshmiri A (2018) Diagnostic Value of D-dimer in acute myocardial infarction among patients with suspected acute coronary syndrome. Cardiol Res 9(1):17–21. https://doi.org/10.14740/cr620w

    Article  PubMed  PubMed Central  Google Scholar 

  10. Matusik PT, Malecka B, Lelakowski J, Undas A (2019) Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01522-x

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210

    Article  PubMed  Google Scholar 

  12. Dan GA, Iliodromitis K, Scherr D, Marin F, Lenarczyk R, Estner HL, Kostkiewicz M, Dagres N, Lip GYH (2018) Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. Europace 20(8):1382–1387. https://doi.org/10.1093/europace/euy094

    Article  PubMed  Google Scholar 

  13. Santema BT, Chan MMY, Tromp J, Dokter M, van der Wal HH, Emmens JE, Takens J, Samani NJ, Ng LL, Lang CC, van der Meer P, Ter Maaten JM, Damman K, Dickstein K, Cleland JG, Zannad F, Anker SD, Metra M, van der Harst P, de Boer RA, van Veldhuisen DJ, Rienstra M, Lam CSP, Voors AA (2019) The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01513-y

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tseluyko V, Salem FB, Matuzok O (2019) NT-proBNP level as a predictor of atrial fibrillation in patients with acute coronary syndrome. Emerg Med 2(97):101–107. https://doi.org/10.22141/2224-0586.2.97.2019.161650

    Article  Google Scholar 

  15. Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J (2019) Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 108(2):142–149. https://doi.org/10.1007/s00392-018-1332-1

    Article  CAS  PubMed  Google Scholar 

  16. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB (2013) N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol 61(22):2274–2284. https://doi.org/10.1016/j.jacc.2012.11.082

    Article  CAS  PubMed  Google Scholar 

  17. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the cardiovascular health study. Circulation 120(18):1768–1774. https://doi.org/10.1161/circulationaha.109.873265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Svennberg E, Lindahl B, Berglund L, Eggers KM, Venge P, Zethelius B, Rosenqvist M, Lind L, Hijazi Z (2016) NT-proBNP is a powerful predictor for incident atrial fibrillation—validation of a multimarker approach. Int J Cardiol 223:74–81. https://doi.org/10.1016/j.ijcard.2016.08.001

    Article  PubMed  Google Scholar 

  19. Li L, Selvin E, Lutsey PL, Hoogeveen RC, O'Neal WT, Soliman EZ, Chen LY, Alonso A (2018) Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort. Am Heart J 204:119–127. https://doi.org/10.1016/j.ahj.2018.07.008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kaab S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A (2014) B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace 16(10):1426–1433. https://doi.org/10.1093/europace/euu175

    Article  PubMed  PubMed Central  Google Scholar 

  21. Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Kemp Gudmundsdottir K, Fredriksson T, Rosenqvist M (2017) Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design. Europace 19(2):297–302. https://doi.org/10.1093/europace/euw319

    Article  PubMed  Google Scholar 

  22. Svennberg E, Henriksson P, Engdahl J, Hijazi Z, Al-Khalili F, Friberg L, Frykman V (2017) N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation. Heart 103(16):1271–1277. https://doi.org/10.1136/heartjnl-2016-310236

    Article  CAS  PubMed  Google Scholar 

  23. Ghazal F, Theobald H, Rosenqvist M, Al-Khalili F (2019) Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care. PLoS ONE 14(2):e0212974. https://doi.org/10.1371/journal.pone.0212974

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Cai GL, Chen J, Hu CB, Yan ML, Xu QH, Yan J (2014) Value of plasma brain natriuretic peptide levels for predicting postoperative atrial fibrillation: a systemic review and meta-analysis. World J Surg 38(1):51–59. https://doi.org/10.1007/s00268-013-2284-2

    Article  PubMed  Google Scholar 

  25. Simmers D, Potgieter D, Ryan L, Fahrner R, Rodseth RN (2015) The use of preoperative B-type natriuretic peptide as a predictor of atrial fibrillation after thoracic surgery: systematic review and meta-analysis. J Cardiothorac Vasc Anesth 29(2):389–395. https://doi.org/10.1053/j.jvca.2014.05.015

    Article  CAS  PubMed  Google Scholar 

  26. Pu Z, Qi X, Xue T, Liu Z, Wu Y (2019) B-type natriuretic peptide and other risk factors for predicting postoperative atrial fibrillation after thoracic surgery. Thorac Cardiovasc Surg 67(2):120–124. https://doi.org/10.1055/s-0037-1609037

    Article  PubMed  Google Scholar 

  27. Carrera P, Thongprayoon C, Cheungpasitporn W, Iyer VN, Moua T (2016) Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit. J Crit Care 36:102–106. https://doi.org/10.1016/j.jcrc.2016.06.032

    Article  PubMed  Google Scholar 

  28. Augusto JB, Fernandes A, Freitas PT, Gil V, Morais C (2018) Predictors of de novo atrial fibrillation in a non-cardiac intensive care unit. Rev Bras Ter Intensiva 30(2):166–173. https://doi.org/10.5935/0103-507X.20180022

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chokengarmwong N, Yeh DD, Chang Y, Ortiz LA, Kaafarani HMA, Fagenholz P, King DR, DeMoya M, Butler K, Lee J, Velmahos G, Januzzi JL, Lee-Lewandrowski E, Lewandrowski K (2017) Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients. J Trauma Acute Care Surg 83(3):485–490. https://doi.org/10.1097/ta.0000000000001552

    Article  CAS  PubMed  Google Scholar 

  30. Philipson DJ, Rader F, Siegel RJ (2019) Risk factors for atrial fibrillation in hypertrophic cardiomyopathy. Eur J Prev Cardiol:2047487319828474. doi:10.1177/2047487319828474

  31. Tuluce K, Yakar Tuluce S, Kahya Eren N, Kocabas U, Akyildiz Akcay F, Gunduz R, Akyildiz ZI, Ergene O (2016) Predictors of future atrial fibrillation development in patients with hypertrophic cardiomyopathy: a prospective follow-up study. Echocardiography 33(3):379–385. https://doi.org/10.1111/echo.13093

    Article  PubMed  Google Scholar 

  32. Tuluce K, Ozerkan F, Yakar Tuluce S, Yavuzgil O, Gurgun C, Bilgin M, Kahya Eren N, Kocabas U, Nalbantgil S, Soydas Cinar C (2015) Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy. Cardiol J 22(1):94–100. https://doi.org/10.5603/CJ.a2014.0025

    Article  PubMed  Google Scholar 

  33. Gao X, Zeng R, Liao P, Zhu H, Zhang M (2016) Relation of N-terminal pro-brain natriuretic peptide and new-onset atrial fibrillation in patients with acute coronary syndrome: a systematic review and meta-analysis. Scand J Clin Lab Invest 76(6):460–464. https://doi.org/10.1080/00365513.2016.1199048

    Article  CAS  PubMed  Google Scholar 

  34. De With RR, Marcos EG, Van Gelder IC, Rienstra M (2018) Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation. Europace 20(11):1750–1757. https://doi.org/10.1093/europace/euy028

    Article  PubMed  Google Scholar 

  35. Zeemering S, Lankveld TAR, Bonizzi P, Limantoro I, Bekkers S, Crijns H, Schotten U (2018) The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation. Europace 20(7):e96–e104. https://doi.org/10.1093/europace/eux234

    Article  PubMed  Google Scholar 

  36. Dudink E, Erkuner O, Berg J, Nieuwlaat R, de Vos CB, Weijs B, Capucci A, Camm AJ, Breithardt G, Le Heuzey JY, Luermans J, Crijns H (2018) The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace 20(6):929–934. https://doi.org/10.1093/europace/eux217

    Article  PubMed  Google Scholar 

  37. Buttner P, Schumacher K, Dinov B, Zeynalova S, Sommer P, Bollmann A, Husser D, Hindricks G, Kornej J (2018) Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: association with atrial fibrillation progression phenotypes. Heart Rhythm 15(8):1132–1137. https://doi.org/10.1016/j.hrthm.2018.03.021

    Article  PubMed  Google Scholar 

  38. Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP (2019) B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Heart 105(5):370–377. https://doi.org/10.1136/heartjnl-2018-313642

    Article  CAS  PubMed  Google Scholar 

  39. Stanciu AE, Vatasescu RG, Stanciu MM, Serdarevic N, Dorobantu M (2018) The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Cytokine 103:63–68. https://doi.org/10.1016/j.cyto.2017.12.026

    Article  CAS  PubMed  Google Scholar 

  40. Clarnette JA, Brooks AG, Mahajan R, Elliott AD, Twomey DJ, Pathak RK, Kumar S, Munawar DA, Young GD, Kalman JM, Lau DH, Sanders P (2018) Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace 20(Fi_3):f366–f376. https://doi.org/10.1093/europace/eux297

    Article  PubMed  Google Scholar 

  41. Fink T, Metzner A, Willems S, Eckardt L, Ince H, Brachmann J, Spitzer SG, Deneke T, Schmitt C, Hochadel M, Senges J, Rillig A (2019) Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the german ablation registry. Clin Res Cardiol 108(12):1354–1363. https://doi.org/10.1007/s00392-019-01471-5

    Article  PubMed  Google Scholar 

  42. Yao Y, Yao W, Bai R, Lu ZH, Tang RB, Long DY, Jiang CX, Sang CH, Zhang JQ, Yu RH, Du X, Liu XH, Dong JZ, Ma CS (2017) Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation. Europace 19(1):66–71. https://doi.org/10.1093/europace/euw081

    Article  PubMed  Google Scholar 

  43. Fiala M, Bulkova V, Sknouril L, Nevralova R, Toman O, Januska J, Spinar J, Wichterle D (2017) Functional improvement after successful catheter ablation for long-standing persistent atrial fibrillation. Europace 19(11):1781–1789. https://doi.org/10.1093/europace/euw282

    Article  PubMed  Google Scholar 

  44. Sepehri Shamloo A, Dagres N, Dinov B, Sommer P, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A (2019) Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? a systematic review and meta-analysis. Int J Cardiol Heart Vasc 22:132–138. https://doi.org/10.1016/j.ijcha.2019.01.003

    Article  PubMed  PubMed Central  Google Scholar 

  45. Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, Waktare JEP, Todd DM, Hall MCS, Snowdon RL, Modi S, Gupta D (2017) Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace 19(5):775–783. https://doi.org/10.1093/europace/euw105

    Article  PubMed  Google Scholar 

  46. Kapur S, Kumar S, John RM, Stevenson WG, Tedrow UB, Koplan BA, Epstein LM, MacRae CA, Michaud GF (2018) Family history of atrial fibrillation as a predictor of atrial substrate and arrhythmia recurrence in patients undergoing atrial fibrillation catheter ablation. Europace 20(6):921–928. https://doi.org/10.1093/europace/eux107

    Article  PubMed  Google Scholar 

  47. Kim TH, Lee JS, Uhm JS, Joung B, Lee MH, Pak HN (2018) High circulating adiponectin level is associated with poor clinical outcome after catheter ablation for paroxysmal atrial fibrillation. Europace 20(8):1287–1293. https://doi.org/10.1093/europace/eux173

    Article  PubMed  Google Scholar 

  48. Mesquita J, Ferreira AM, Cavaco D, Moscoso Costa F, Carmo P, Marques H, Morgado F, Mendes M, Adragao P (2018) Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure-ATLAS score. Europace 20(Fi_3):f428–f435. https://doi.org/10.1093/europace/eux265

    Article  PubMed  Google Scholar 

  49. Kosich F, Schumacher K, Potpara T, Lip GY, Hindricks G, Kornej J (2019) Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation. Clin Cardiol 42(2):320–329

    Article  Google Scholar 

  50. Jiang H, Wang W, Wang C, Xie X, Hou Y (2017) Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis. Europace 19(3):392–400. https://doi.org/10.1093/europace/euw088

    Article  PubMed  Google Scholar 

  51. Miake J, Kato M, Ogura K, Iitsuka K, Okamura A, Tomomori T, Tsujimoto D, Kato M, Yamamoto K (2019) Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation. Heart Vessels 34(3):517–526. https://doi.org/10.1007/s00380-018-1267-5

    Article  PubMed  Google Scholar 

  52. Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, Fukumoto K, Aizawa Y, Tanimoto Y, Tanimoto K, Fukuda K (2014) Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation. Heart Lung Circ 23(7):636–643. https://doi.org/10.1016/j.hlc.2014.02.003

    Article  PubMed  Google Scholar 

  53. Pillarisetti J, Reddy N, Biria M, Ryschon K, Nagarajan D, Murray C, Atkins D, Bommana S, Reddy MY, DiBiase L, Pimentel R, Berenbom L, Dawn B, Natale A, Lakkireddy D (2014) Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time? J Interv Card Electrophysiol 40(2):161–168. https://doi.org/10.1007/s10840-014-9898-7

    Article  PubMed  Google Scholar 

  54. Zhang Y, Chen A, Song L, Li M, Chen Y, He B (2016) Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation. Int Heart J 57(2):183–189. https://doi.org/10.1536/ihj.15-355

    Article  CAS  PubMed  Google Scholar 

  55. Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH (2018) Evaluation of a novel cardioversion intervention for atrial fibrillation: the ottawa AF cardioversion protocol. Europace. https://doi.org/10.1093/europace/euy285

    Article  PubMed  PubMed Central  Google Scholar 

  56. Frederiksen AS, Albertsen AE, Christesen AMS, Vinter N, Frost L, Moller DS (2018) Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin. Europace 20(7):1078–1085. https://doi.org/10.1093/europace/eux188

    Article  PubMed  Google Scholar 

  57. Ebert M, Stegmann C, Kosiuk J, Dinov B, Richter S, Arya A, Mussigbrodt A, Sommer P, Hindricks G, Bollmann A (2018) Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation. Europace 20(9):1428–1434. https://doi.org/10.1093/europace/eux327

    Article  PubMed  Google Scholar 

  58. Bartkowiak R, Wozakowska-Kaplon B, Janiszewska G (2010) Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion. Kardiol Pol 68(1):48–54

    PubMed  Google Scholar 

  59. Xu X, Tang Y (2017) Relationship between brain natriuretic peptide and recurrence of atrial fibrillation after successful electrical cardioversion: an updated meta-analysis. Braz J Cardiovasc Surg 32(6):530–535. https://doi.org/10.21470/1678-9741-2017-0008

    Article  PubMed  PubMed Central  Google Scholar 

  60. Zografos T, Maniotis C, Katsivas A, Katritsis D (2014) Relationship between brain natriuretic peptides and recurrence of atrial fibrillation after successful direct current cardioversion: a meta-analysis. Pacing Clin Electrophysiol 37(11):1530–1537. https://doi.org/10.1111/pace.12477

    Article  PubMed  Google Scholar 

  61. Raman K, Aeschbacher S, Bossard M, Hochgruber T, Zimmermann AJ, Kaufmann BA, Pumpol K, Rickenbacker P, Pare G, Conen D (2016) Whole blood gene expression differentiates between atrial fibrillation and sinus rhythm after cardioversion. PLoS ONE 11(6):e0157550. https://doi.org/10.1371/journal.pone.0157550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Kornej J, Schumacher K, Husser D, Hindricks G (2018) Biomarkers and atrial fibrillation : prediction of recurrences and thromboembolic events after rhythm control management. Herzschrittmacherther Elektrophysiol 29(2):219–227. https://doi.org/10.1007/s00399-018-0558-y

    Article  PubMed  Google Scholar 

  63. Lewicka E, Dudzinska-Gehrmann J, Dabrowska-Kugacka A, Zagozdzon P, Stepnowska E, Lizewska A, Kozlowski D, Raczak G (2015) Plasma biomarkers as predictors of recurrence of atrial fibrillation. Pol Arch Med Wewn 125(6):424–433

    PubMed  Google Scholar 

  64. Hylek Elaine M (2019) Biomarkers for prediction of stroke and bleeds in atrial fibrillation. Circulation 139(6):772–774. https://doi.org/10.1161/CIRCULATIONAHA.118.038635

    Article  CAS  PubMed  Google Scholar 

  65. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbuchel H (2018) The 2018 EUROPEAN HEART RHYTHM ASSOCIATION PRACTICAL GUIDE on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace 20(8):1231–1242. https://doi.org/10.1093/europace/euy054

    Article  PubMed  Google Scholar 

  66. Hart RG, Pearce LA, Koudstaal PJ (2004) Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial. Stroke 35(4):948–951. https://doi.org/10.1161/01.str.0000120741.34866.1d

    Article  PubMed  Google Scholar 

  67. Bai Y, Guo SD, Shantsila A, Lip GYH (2018) Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death. Europace 20(10):1584–1590. https://doi.org/10.1093/europace/eux328

    Article  PubMed  Google Scholar 

  68. Heidbuchel H, Dagres N, Antz M, Kuck KH, Lazure P, Murray S, Carrera C, Hindricks G, Vahanian A (2018) Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment. Europace 20(12):1919–1928. https://doi.org/10.1093/europace/euy039

    Article  PubMed  Google Scholar 

  69. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6(2):92–96

    Article  CAS  Google Scholar 

  70. Roldan V, Marin F, Muina B, Torregrosa JM, Hernandez-Romero D, Valdes M, Vicente V, Lip GY (2011) Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol 57(25):2496–2504. https://doi.org/10.1016/j.jacc.2010.12.033

    Article  CAS  PubMed  Google Scholar 

  71. Cushman M, Judd SE, Howard VJ, Kissela B, Gutierrez OM, Jenny NS, Ahmed A, Thacker EL, Zakai NA (2014) N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke 45(6):1646–1650. https://doi.org/10.1161/strokeaha.114.004712

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation 125(13):1605–1616. https://doi.org/10.1161/circulationaha.111.038729

    Article  CAS  Google Scholar 

  73. Hijazi Z, Lindback J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L (2016) The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J 37(20):1582–1590. https://doi.org/10.1093/eurheartj/ehw054

    Article  PubMed  PubMed Central  Google Scholar 

  74. Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA (2019) Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48. Circulation 139(6):760–771. https://doi.org/10.1161/CIRCULATIONAHA.118.038312

    Article  PubMed  PubMed Central  Google Scholar 

  75. Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodriguez-Yanez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Jafarian Kerman SR, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, Garcia-Berrocoso T, Montaner J (2015) B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis. Stroke 46(5):1187–1195. https://doi.org/10.1161/strokeaha.114.008311

    Article  CAS  PubMed  Google Scholar 

  76. Fu S, Jiao J, Guo Y, Zhu B, Luo L (2019) N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation. BMC Geriatr 19(1):56. https://doi.org/10.1186/s12877-019-1051-0

    Article  PubMed  PubMed Central  Google Scholar 

  77. Roldan V, Vilchez JA, Manzano-Fernandez S, Jover E, Galvez J, Puche CM, Valdes M, Vicente V, Lip GY, Marin F (2014) Usefulness of N-terminal pro-B-type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke 45(3):696–701. https://doi.org/10.1161/strokeaha.113.003338

    Article  CAS  PubMed  Google Scholar 

  78. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Siegbahn A, Yusuf S, Wallentin L (2014) Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy. Heart 100(15):1193–1200. https://doi.org/10.1136/heartjnl-2013-304872

    Article  PubMed  Google Scholar 

  79. Holl MJ, van den Bos EJ, van Domburg RT, Fouraux MA, Kofflard MJ (2018) NT-proBNP is associated with mortality and adverse cardiac events in patients with atrial fibrillation presenting to the emergency department. Clin Cardiol 41(3):400–405. https://doi.org/10.1002/clc.22883

    Article  PubMed  PubMed Central  Google Scholar 

  80. Niederdockl J, Simon A, Schnaubelt S, Schuetz N, Laggner R, Sulzgruber P, Spiel AO, Herkner H, Laggner AN, Domanovits H (2019) Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation. Heart 105(6):482–488. https://doi.org/10.1136/heartjnl-2018-313145

    Article  PubMed  Google Scholar 

  81. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350(7):655–663. https://doi.org/10.1056/NEJMoa031994

    Article  CAS  PubMed  Google Scholar 

  82. Schnabel RB, Wild PS, Wilde S, Ojeda FM, Schulz A, Zeller T, Sinning CR, Kunde J, Lackner KJ, Munzel T, Blankenberg S (2014) Multiple biomarkers and atrial fibrillation in the general population. PLoS ONE 9(11):e112486. https://doi.org/10.1371/journal.pone.0112486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Patton KK, Heckbert SR, Alonso A, Bahrami H, Lima JA, Burke G, Kronmal RA (2013) N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the multi-ethnic study of atherosclerosis: the effects of age, sex and ethnicity. Heart 99(24):1832–1836. https://doi.org/10.1136/heartjnl-2013-304724

    Article  CAS  PubMed  Google Scholar 

  84. Kumarathurai P, Mouridsen MR, Mattsson N, Larsen BS, Nielsen OW, Gerds TA, Sajadieh A (2017) Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study. Europace 19(3):364–370. https://doi.org/10.1093/europace/euw017

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Electrophysiology, Leipzig Heart Institute, Heart Center Leipzig at University of Leipzig, Strümpellstrasse 39, 04289, Leipzig, Germany

    Alireza Sepehri Shamloo, Andreas Bollmann, Nikolaos Dagres, Gerhard Hindricks & Arash Arya

Authors
  1. Alireza Sepehri Shamloo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Bollmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolaos Dagres
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerhard Hindricks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arash Arya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alireza Sepehri Shamloo.

Ethics declarations

Conflict of interest

Drs Bollmann, Dagres and Hindricks report research grants from Abbott and Boston Scientific to the institution without personal financial benefits. Other authors do not declare any conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (ZIP 1969 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sepehri Shamloo, A., Bollmann, A., Dagres, N. et al. Natriuretic peptides: biomarkers for atrial fibrillation management. Clin Res Cardiol 109, 957–966 (2020). https://doi.org/10.1007/s00392-020-01608-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-020-01608-x

Keywords

Search

Navigation